NeuroLift + Uthrive Health: Advanced Psychiatric Care in New Port Richey

Research. Innovation. Clarity. Results.

NeuroLift has partnered with Uthrive Health to bring advanced, evidence-based psychiatric treatments to the New Port Richey community. Together, we are committed to providing cutting-edge therapies in a compassionate and supportive environment.

Our Services in New Port Richey

At our Grand Boulevard location, patients can access specialized treatments designed for individuals struggling with depression and other mental health conditions:

Transcranial Magnetic Stimulation (TMS) with MagVenture: Transcranial Magnetic Stimulation (TMS) with the MagVenture system is a cutting-edge, non-invasive, FDA-approved therapy that uses advanced magnetic technology to stimulate targeted areas of the brain involved in mood regulation. Unlike medications, which affect the entire body and can cause systemic side effects, MagVenture TMS delivers precise stimulation directly to the regions associated with depression and related conditions. As a leading-edge TMS technology, MagVenture offers enhanced accuracy, patient comfort, and treatment efficiency. This therapy is particularly effective for individuals who have not achieved sufficient relief from traditional antidepressants or who prefer a non-drug treatment option. Treatments are performed while patients remain fully awake and alert, require no anesthesia, and involve little to no downtime, making MagVenture TMS a safe, well-tolerated, and highly effective solution for improving mental health and overall quality of life.

Call us today to schedule a consultation and learn how our specialized programs and advanced treatments can support your mental wellness. Or Complete this questionnaire to discover care that lifts you forward.

Spravato® (Esketamine) Therapy: Spravato® (Esketamine) is an innovative, FDA-approved treatment specifically designed for individuals with treatment-resistant depression who have not responded adequately to traditional antidepressants. Administered as a nasal spray in a controlled clinical setting, it allows healthcare professionals to carefully monitor patients for safety and effectiveness. Spravato® works differently from standard antidepressants by targeting the brain’s NMDA receptors, promoting rapid improvement in mood and depressive symptoms. Treatments are personalized, with dosing and frequency tailored to each patient’s unique needs, ensuring optimal outcomes. Under the supervision of trained clinicians, Spravato® offers a safe, evidence-based, and transformative approach to managing depression and improving overall quality of life.

Transcranial Magnetic Stimulation (TMS) with MagVenture

Transcranial Magnetic Stimulation (TMS) with the MagVenture system is a cutting-edge, non-invasive, FDA-approved therapy that uses advanced magnetic technology to stimulate targeted areas of the brain involved in mood regulation. Unlike medications, which affect the entire body and can cause systemic side effects, MagVenture TMS delivers precise stimulation directly to the regions associated with depression and related conditions. As a leading-edge TMS technology, MagVenture offers enhanced accuracy, patient comfort, and treatment efficiency. This therapy is particularly effective for individuals who have not achieved sufficient relief from traditional antidepressants or who prefer a non-drug treatment option. Treatments are performed while patients remain fully awake and alert, require no anesthesia, and involve little to no downtime, making MagVenture TMS a safe, well-tolerated, and highly effective solution for improving mental health and overall quality of life.

Spravato® (Esketamine) Therapy

Spravato® (Esketamine) is an innovative, FDA-approved treatment specifically designed for individuals with treatment-resistant depression who have not responded adequately to traditional antidepressants. Administered as a nasal spray in a controlled clinical setting, it allows healthcare professionals to carefully monitor patients for safety and effectiveness. Spravato® works differently from standard antidepressants by targeting the brain’s NMDA receptors, promoting rapid improvement in mood and depressive symptoms. Treatments are personalized, with dosing and frequency tailored to each patient’s unique needs, ensuring optimal outcomes. Under the supervision of trained clinicians, Spravato® offers a safe, evidence-based, and transformative approach to managing depression and improving overall quality of life.

On-Site Leadership & Care Team

Hassan A. Bokhari, MD

Medical Director

Dr. Bokhari is a leader in modern psychiatric care, serving as the Medical Director for NeuroLift and guiding innovative mental health programs in partnership with Uthrive. He specializes in TMS with the MagVenture system and Spravato® therapy, providing non-invasive, evidence-based treatments for individuals seeking alternatives to traditional medications. With a focus on personalized care, Dr. Bokhari designs treatment plans that are tailored to each patient’s unique needs while maintaining the highest standards of safety and effectiveness. Combining advanced clinical expertise with genuine compassion, he creates a supportive environment where patients feel empowered throughout their mental health journey.

Dr. Genci Shkembi, DNP, FNP-C, PMHNP-BC

Site Clinician

As a partner of Neurolift , owner of Uthrive Health, and a dedicated psychiatric nurse practitioner, Genci Shkembi brings a unique blend of leadership, expertise, and compassionate care to the New Port Richey location. He is committed to delivering patient-centered treatment that is personalized, ensuring every individual receives the support they need throughout their mental health journey. Through his guidance, patients have access to the latest innovations in psychiatric care, combining cutting-edge therapies with a thoughtful, empathetic approach. His dedication empowers patients to achieve meaningful, lasting improvements in mood, cognition, and overall well-being.

Our Location

Uthrive Health – in partnership with NeuroLift

Conveniently located in the heart of Port Richey, our clinic offers a welcoming space where patients can access advanced therapies close to home.

5411 Grand Blvd, Suite 109
New Port Richey, FL 34652

Why Choose NeuroLift + Uthrive?

Expertise guided by Dr. Hassan Bokhari, MD, NeuroLift’s Medical Director

Access to the latest innovations in psychiatric treatment

Personalized care tailored to each patient’s unique needs

A collaborative team dedicated to your long-term mental wellness

Take the Next Step

If you or a loved one is struggling with depression, it may be time to explore advanced therapies like TMS or Spravato®.